Literature DB >> 35367297

Decreased progression to systemic lupus erythematosus in patients with cutaneous lupus erythematosus under European League Against Rheumatism/American College of Rheumatology criteria.

Amanda M Walker1, Samantha M Black1, Frances Walocko1, Xilong Li2, Benjamin F Chong3.   

Abstract

Entities:  

Keywords:  classification criteria; cutaneous lupus erythematosus; disease progression; systemic lupus erythematosus

Year:  2022        PMID： 35367297      PMCID： PMC9522890          DOI： 10.1016/j.jaad.2022.03.048

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   15.487


× No keyword cloud information.
  5 in total

1.  Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).

Authors:  Janice Tiao; Rui Feng; Kasey Carr; Joyce Okawa; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2016-02-18       Impact factor: 11.527

2.  Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study.

Authors:  Olayemi Durosaro; Mark D P Davis; Kurtis B Reed; Audrey L Rohlinger
Journal:  Arch Dermatol       Date:  2009-03

3.  Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus.

Authors:  Isabela T Wieczorek; Kathleen J Propert; Joyce Okawa; Victoria P Werth
Journal:  JAMA Dermatol       Date:  2014-03       Impact factor: 10.282

4.  Development of systemic lupus in patients with cutaneous lupus using the 2012 Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for systemic lupus erythematosus.

Authors:  Samantha M Black; Frances Walocko; Xilong Li; Benjamin F Chong
Journal:  J Am Acad Dermatol       Date:  2021-01-07       Impact factor: 15.487

5.  2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Authors:  Martin Aringer; Karen Costenbader; David Daikh; Ralph Brinks; Marta Mosca; Rosalind Ramsey-Goldman; Josef S Smolen; David Wofsy; Dimitrios T Boumpas; Diane L Kamen; David Jayne; Ricard Cervera; Nathalie Costedoat-Chalumeau; Betty Diamond; Dafna D Gladman; Bevra Hahn; Falk Hiepe; Søren Jacobsen; Dinesh Khanna; Kirsten Lerstrøm; Elena Massarotti; Joseph McCune; Guillermo Ruiz-Irastorza; Jorge Sanchez-Guerrero; Matthias Schneider; Murray Urowitz; George Bertsias; Bimba F Hoyer; Nicolai Leuchten; Chiara Tani; Sara K Tedeschi; Zahi Touma; Gabriela Schmajuk; Branimir Anic; Florence Assan; Tak Mao Chan; Ann Elaine Clarke; Mary K Crow; László Czirják; Andrea Doria; Winfried Graninger; Bernadett Halda-Kiss; Sarfaraz Hasni; Peter M Izmirly; Michelle Jung; Gábor Kumánovics; Xavier Mariette; Ivan Padjen; José M Pego-Reigosa; Juanita Romero-Diaz; Íñigo Rúa-Figueroa Fernández; Raphaèle Seror; Georg H Stummvoll; Yoshiya Tanaka; Maria G Tektonidou; Carlos Vasconcelos; Edward M Vital; Daniel J Wallace; Sule Yavuz; Pier Luigi Meroni; Marvin J Fritzler; Ray Naden; Thomas Dörner; Sindhu R Johnson
Journal:  Arthritis Rheumatol       Date:  2019-08-06       Impact factor: 15.483
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.